Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
1.
Eur J Gynaecol Oncol ; 35(6): 741-4, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25556286

RESUMEN

INTRODUCTION: Paratubal cysts are common incidental finding, but malignant paratubal cancers have rare occurrence and have not been sufficiently described and discussed in previous studies. CASE REPORT: This report describes a case of a 70-year-old female who underwent emergent laparoscopy for adnexal torsion. A serous cystadenocarcinoma arising in a paratubal cyst and accompanied by tubal torsion was revealed by frozen section and successfully treated with laparoscopic cytoreductive surgery and adjuvant chemotherapy. CONCLUSION: This report is the first case of paratubal cancer with bilateral tubal torsion which was diagnosed and treated with laparoscopic surgery, and the third report describing serous cystadenocarcinoma arising in a paratubal cyst. In the laparoscopic surgery for the paratubal cyst clinically presumed as accompanied with tubal torsion, surgeons should not ignore the possibility of malignancy in spite of the rare incidence of paratubal cancers and the preconception that adnexal malignancies are seldom accompanied by tubal torsion.


Asunto(s)
Cistadenocarcinoma Seroso/patología , Enfermedades de las Trompas Uterinas/cirugía , Neoplasias de las Trompas Uterinas/patología , Laparoscopía , Anomalía Torsional/cirugía , Anciano , Femenino , Humanos , Quiste Paraovárico/patología
2.
Eur J Gynaecol Oncol ; 34(3): 238-42, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23967554

RESUMEN

Nestin is an intermediate filament protein expressed in proliferating cells during embryonic development of the central nervous system (CNS) and considered to be a neuronal stem cell/progenitor cell marker. This study investigated the difference of nestin expression between pre-cancer (carcinoma in situ - CIS) and cancer of cervix in 129 tissues (49 normal cervix, 41 CIS, and 39 invasive cervical cancer) through the use of a paraffin-embedded tissue array. Immunostaining was evaluated by intensity, proportion of stained cells, and pattern of expression. The expression of nestin was positive in 63.4% (26/41) for CIS and 43.6% (17/39) for invasive cervical cancer, but only 26.5% (13/49) for normal tissues (p = 0.002). Strong positive staining/large proportion staining were 53.7% (22/41) / 36.6% (15/41), 15.4% (6/39) / 61.5% (24/39) in the CIS and invasive cervical cancer tissues, respectively (p = 0.043, p < 0.001). The diffuse stain with basal layer was positive in 90.2% (37/41) for CIS, but only 24.5% (12/49) of the samples were positive in normal tissues (p < 0.001). Based on these results, the authors suggest that nestin expression seems to participate in the step of cancer initiation and could potentially be a useful marker in the early detection of cervical cancer.


Asunto(s)
Carcinoma in Situ/química , Proteínas de Filamentos Intermediarios/análisis , Proteínas del Tejido Nervioso/análisis , Neoplasias del Cuello Uterino/química , Biomarcadores de Tumor/análisis , Cuello del Útero/química , Detección Precoz del Cáncer , Femenino , Humanos , Inmunohistoquímica , Nestina , Neoplasias del Cuello Uterino/diagnóstico
3.
J Int Med Res ; 40(2): 486-96, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22613409

RESUMEN

OBJECTIVE: This study aimed to identify factors that predict clearance of high-risk human papillomavirus (HPV) infection and progression to cervical intraepithelial neoplasia (CIN) 2 or higher, in women with normal cervical histology or CIN 1. METHODS: A retrospective analysis was performed on 817 high-risk HPV-infected women with histologically verified CIN 1 or normal cervical histology. Patients were followed-up for a maximum of 24 months. Cervical HPV DNA tests were performed at every visit. RESULTS: At the end of followup, 648/817 (79.3%) patients were free from HPV infection and 66/817 patients (8.1%) progressed to CIN 2 or higher. Age, parity, cytology and viral load at diagnosis were significantly and inversely associated with HPV clearance. Cytology, viral load and presence of CIN 1 lesions were significantly associated with lesion progression. CONCLUSIONS: Cytology and high-risk HPV viral load may be useful markers for the likelihood of high-risk HPV clearance and lesion progression. Histological status, parity and marital status may also be useful factors to consider when predicting progression.


Asunto(s)
Infecciones por Papillomavirus/diagnóstico , Infecciones por Papillomavirus/virología , Displasia del Cuello del Útero/virología , Neoplasias del Cuello Uterino/virología , Adulto , Cuello del Útero/patología , Cuello del Útero/virología , ADN Viral/sangre , Progresión de la Enfermedad , Femenino , Humanos , Persona de Mediana Edad , Papillomaviridae/genética , Estudios Retrospectivos , Neoplasias del Cuello Uterino/patología , Frotis Vaginal , Carga Viral , Adulto Joven , Displasia del Cuello del Útero/patología
4.
Eur J Gynaecol Oncol ; 32(2): 221-3, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21614923

RESUMEN

BACKGROUND: The incidence of bone metastasis is low in metastatic cervical cancer, especially in the case of adenocarcinoma. Incidental finding of a mass located in an unusual metastatic site in the absence of identifiable primary tumor often results in a difficult diagnostic problem. CASE REPORT: We report the case of a 59-year-old woman presenting left-sided foot drop as her initial symptom. At first, after performing lumbar spine magnetic resonance imaging (MRI), a huge paravertebral mass with ipsilateral psoas muscle involvement suggesting retroperitoneal sarcoma was identified. However, cervical punch biopsy and sono-guided paravertebral mass biopsy revealed cervical adenocarcinoma with lumbar spinal metastasis. CONCLUSION: Although rare, a neurological symptom such as foot drop, not vaginal symptoms, in a woman may be a first manifestation of metastatic cervical cancer, especially in spinal metastasis. Furthermore, any abnormal lesion should not be ignored because of the possibility of metastasis from the primary malignancy, especially in the current case of cervical adenocarcinoma, so a complete evaluation is always mandatory.


Asunto(s)
Adenocarcinoma/secundario , Vértebras Lumbares , Neoplasias de los Músculos/secundario , Neoplasias Retroperitoneales/secundario , Sarcoma/patología , Neoplasias de la Columna Vertebral/secundario , Neoplasias del Cuello Uterino/patología , Diagnóstico Diferencial , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Músculos Psoas/patología
5.
Eur J Gynaecol Oncol ; 32(2): 231-3, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21614927

RESUMEN

BACKGROUND: 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) adds to conventional imaging in the detection and staging of peritoneal carcinomatosis. CASE REPORT: Herein we report a 27-year-old woman with multiple intraperitoneal masses detected by 18F-FDG-PET, suggesting peritoneal carcinomatosis. She had undergone laparoscopic unilateral oophorectomy for a left ovarian mucinous borderline tumor approximately five years before. Based on imaging and intraoperative findings, multiple intraabdominal masses strongly suggested peritoneal recurrence from a previous ovarian borderline tumor, but it finally proved to be inflammation and fibrosis on histopathologic examination. CONCLUSION: Although 18F-FDG-PET is well known to be a highly sensitive imaging tool for identification of peritoneal carcinomatosis, FDG uptake is not tumor-specific. Therefore, the possibility of a false-positive diagnosis due to benign conditions, such as inflammation, should always be taken into consideration.


Asunto(s)
Adenocarcinoma Mucinoso/cirugía , Carcinoma/diagnóstico por imagen , Fibrosis/diagnóstico por imagen , Inflamación/diagnóstico por imagen , Neoplasias Ováricas/cirugía , Neoplasias Peritoneales/diagnóstico por imagen , Adulto , Diagnóstico Diferencial , Errores Diagnósticos , Femenino , Fluorodesoxiglucosa F18 , Humanos , Tomografía de Emisión de Positrones , Recurrencia
6.
Cytopathology ; 22(4): 261-8, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20636403

RESUMEN

OBJECTIVE: To establish an efficient multiplex real-time PCR assay for 15 human papillomavirus (HPV) genotypes, we designed multiplexing parameters and compared our PCR system with the hybrid capture (HC) II test using cervical cytology samples. METHODS: For preventing cross-reactive amplifications, variable HPV genes (E1, E2, E6, E7 and L1) were targeted. The melting temperatures of all primers and probes, and the size of the PCR product were optimized for the multiplex PCR. Our PCR system was compared with the HC II assays in the detection and genotyping of HPV infection using 173 cytology smears. Discordant cases between the two assays were verified by direct HPV DNA sequencing. RESULTS: Of 173 women, 93 (53.8%) were HPV-positive by the HC II assay and/or the multiplex real-time PCR assay. The HPV genotypes were determined in 92 (98.9%) of 93 cases by the multiplex real-time PCR and/or DNA sequencing. The agreement rate between multiplex PCR and HC II methods was 91.9% (kappa=0.84). Although the sample size of this study needs to be increased to have epidemiological significance, multiple infections and HPV 16 were the predominant type. HPV 58, 52 and 18 accounted for 25% of HPV infections. HPV 52, 58 and 31 constituted 30% of CIN 2/3. CONCLUSION: The multiplex real-time PCR system shows a good and reliable clinical performance. This in house PCR assay is fast and cost-effective for HPV genotyping and the detection of HPV co-infection in the post-HPV vaccination era.


Asunto(s)
Papillomaviridae/clasificación , Infecciones por Papillomavirus/patología , Infecciones por Papillomavirus/virología , Reacción en Cadena de la Polimerasa/métodos , Neoplasias del Cuello Uterino/patología , Neoplasias del Cuello Uterino/virología , Femenino , Genotipo , Humanos , Papillomaviridae/genética , Papillomaviridae/aislamiento & purificación , Reproducibilidad de los Resultados
7.
Eur J Gynaecol Oncol ; 31(2): 214-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20527245

RESUMEN

Primary serous papillary carcinoma of the peritoneum is a rare tumor, histologically similar to primary ovarian carcinoma. Pelvic CT and MRI are helpful to diagnose primary carcinoma of the peritoneum. We present a case of primary serous carcinoma of the peritoneum mimicking pelvic actinomycosis in a 59-year-old woman. Pelvic CT and MRI suggested pelvic actinomycosis. Exploratory laparotomy was performed to remove the mass and the diagnosis was confirmed by pathology. A subtotal hysterectomy, left salpingo-oophorectomy and omentectomy were performed. Histopathology examination revealed peritoneal carcinomatosis and primary serous carcinoma of the peritoneum. Pelvic CT and MRI were limited in their ability to differentiate inflammation, such as actinomycosis, from primary carcinoma of the peritoneum.


Asunto(s)
Actinomicosis/diagnóstico , Cistadenocarcinoma Papilar/diagnóstico , Cistadenocarcinoma Seroso/diagnóstico , Enfermedades Peritoneales/diagnóstico , Neoplasias Peritoneales/diagnóstico , Quimioterapia Adyuvante , Cistadenocarcinoma Papilar/tratamiento farmacológico , Cistadenocarcinoma Papilar/cirugía , Cistadenocarcinoma Seroso/tratamiento farmacológico , Cistadenocarcinoma Seroso/cirugía , Diagnóstico Diferencial , Femenino , Humanos , Histerectomía , Persona de Mediana Edad , Neoplasias Peritoneales/tratamiento farmacológico , Neoplasias Peritoneales/cirugía
8.
Int J Gynecol Cancer ; 18(6): 1352-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18217976

RESUMEN

The pituitary tumor-transforming gene (PTTG) is a novel oncogene expressed abundantly in most tumors, regulates basic fibroblast growth factor secretion, and induces angiogenesis. The objective of this study is to compare the expression rate of PTTG in endometrial cells, to correlate the level of expression of PTTG with the clinicopathologic parameters and overall survival, and to evaluate the possible use of PTTG as a prognostic marker of endometrial cancer. Forty patients diagnosed with endometrial cancer, 20 patients with endometrial hyperplasia, and 20 patients with normal endometrial tissues were included in the study. Immunohistochemical analyses on paraffin-embedded blocks were performed using a polyclonal anti-PTTG antibody. The decrease in expression of cytoplasmic and nuclear PTTG seen for endometrial cancer cells was statistically significant (P < 0.05). Cytoplasmic PTTG expression correlated with expression of progesterone receptor (P = 0.009) and FGF-2 (P = 0.007) but not with other parameters such as the expression of estrogen receptor, tumor grade, and surgical stage. Nuclear PTTG expression did not correlate with any parameters. The mean survival of patients with positive and negative cytoplasmic PTTG expression was 40.8 and 48.6 months (P = 0.78). In nuclear PTTG expression, the survival was 20.0 and 51.8 months, respectively (P = 0.04). Cytoplasmic PTTG expression was not associated with survival. Patients with nuclear PTTG overexpression showed a significant decrease in survival. The use of PTTG as a prognostic marker for endometrial cancer needs further investigation.


Asunto(s)
Biomarcadores de Tumor/genética , Neoplasias Endometriales/genética , Neoplasias Endometriales/patología , Regulación Neoplásica de la Expresión Génica/genética , Proteínas de Neoplasias/genética , Adulto , Anciano , Biomarcadores de Tumor/metabolismo , Neoplasias Endometriales/metabolismo , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Proteínas de Neoplasias/metabolismo , Estadificación de Neoplasias , Pronóstico , Securina , Tasa de Supervivencia
9.
Int J Gynecol Cancer ; 18(5): 1051-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18217980

RESUMEN

The objective of this study was to identify genes that are related to pathogenesis of carcinoma in situ (CIS) to invasive cervical cancer with the use of oligonucleotide microarray and reverse transcription-polymerase chain reaction (RT-PCR). Each two cases of normal cervix, CIS, and invasive cervical cancer were investigated with DNA microarray technology. Differential gene expression profiles among them were analyzed. Expression levels of selected genes from the microarray results were confirmed by RT-PCR. The expressions of 15,286 genes were compared and 458 genes were upregulated or downregulated by twofold or more compared with each other group. Among 458 genes, 22 genes were upregulated and 40 genes were downregulated by twofold or more in invasive cervical cancer group compared with CIS group. RT-PCR analysis confirmed upregulation of 18 genes and downregulation of 5 genes in invasive cervical cancer group. RBP1, TFRC, SPP1, SAA1, ARHGAP8, and NDRG1, which were upregulated, and GATA3, PLAGL1, APOD, DUSP1, and CYR61, which were downregulated, were considered as candidate genes associated with invasion of cervical cancer.


Asunto(s)
Biomarcadores de Tumor/genética , Carcinoma in Situ/genética , Carcinoma in Situ/patología , Regulación Neoplásica de la Expresión Génica/genética , Salud , Neoplasias del Cuello Uterino/genética , Neoplasias del Cuello Uterino/patología , Femenino , Humanos , Análisis por Micromatrices , Invasividad Neoplásica/genética , Invasividad Neoplásica/patología , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN Mensajero/genética
10.
Int J Gynecol Cancer ; 17(4): 858-67, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17367326

RESUMEN

The purpose of this study was to investigate the correlations between high-risk human papillomavirus (HPV) load and p16 (INK4a) or Ki-67, and to identify biomarkers that may predict residual disease after conization with positive margins. The following samples were analyzed: 49 paraffin-embedded specimens from patients with cervical intraepithelial neoplasia (CIN), including 12 CIN 2 conization specimens and 37 CIN 3 conization specimens. Immunohistochemical analysis was performed with antibodies to p16 (INK4a) and Ki-67. Hybrid Capture II testing was used to detect high-risk HPV DNA. The mean HPV loads within each of the p16 (INK4a)-staining cases were 9.5 (relative light units/positive control) RLU/PC for negative staining, 531.8 RLU/PC for 1+ staining, 140.2 RLU/PC for 2+ staining, and 545.1 RLU/PC for 3+ staining. HPV loads differed significantly according to p16 (INK4a) expression (P = 0.0021). The mean HPV loads within Ki-67 staining cases were 28.2 RLU/PC for 1+ staining, 189.6 RLU/PC for 2+ staining, and 563.3 RLU/PC for 3+ staining. HPV loads differed significantly according to Ki-67 expression (P = 0.0259). The expression of p16 (INK4a) (P = 0.0012) and Ki-67 (P = 0.0006) were significantly associated with the CIN grade. In univariate and multiple logistic regression analysis, age, parity, cytology, lesion grade in the cone, high-risk HPV load, and the expression of p16 (INK4a) and Ki-67 were not significantly associated with residual lesions after conization with positive margins (P > 0.05). In conclusion, high-risk HPV load showed significant differences according to the expression of p16 (INK4a) and Ki-67, while none of the prognostic factors were significantly associated with residual disease after conization with positive margins.


Asunto(s)
Biomarcadores de Tumor/biosíntesis , Inhibidor p16 de la Quinasa Dependiente de Ciclina/biosíntesis , Antígeno Ki-67/biosíntesis , Infecciones por Papillomavirus/metabolismo , Displasia del Cuello del Útero/metabolismo , Displasia del Cuello del Útero/virología , Neoplasias del Cuello Uterino/metabolismo , Neoplasias del Cuello Uterino/virología , Adulto , Anciano , Conización/métodos , Femenino , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasia Residual , Infecciones por Papillomavirus/patología , Infecciones por Papillomavirus/virología , Riesgo , Neoplasias del Cuello Uterino/patología , Neoplasias del Cuello Uterino/cirugía , Carga Viral , Displasia del Cuello del Útero/patología , Displasia del Cuello del Útero/cirugía
11.
J Int Med Res ; 34(2): 176-82, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16749413

RESUMEN

We investigated whether monocyte CD14 receptor gene promoter polymorphisms were associated with the development and severity of pre-eclampsia. We genotyped the CD14 -260 C/T polymorphism in 36 pre-eclamptic patients and 52 healthy pregnant controls. A total of 30.6% and 69.4% of pre-eclamptic patients had the C and T alleles, respectively, and 48.0% and 52.0% of the controls, respectively. More pre-eclamptic patients were TT homozygotes compared with controls (50.0% versus 13.5%). In pre-eclamptic patients, the TT homozygotes exhibited a significantly higher mean systolic blood pressure compared with the non-TT homozygotes (173 +/- 28 mmHg versus 153 +/- 22 mmHg). We also noted a tendency towards increased proteinuria and placental abruption in the TT homozygotes compared with the non-TT homozygotes. We conclude that CD14 gene promoter polymorphisms appear to be a risk factor for pre-eclampsia. With further research, these findings might form the basis of a prognostic tool for pre-eclampsia.


Asunto(s)
Receptores de Lipopolisacáridos/genética , Polimorfismo de Nucleótido Simple , Preeclampsia/genética , Preeclampsia/inmunología , Regiones Promotoras Genéticas , Adulto , Alelos , Secuencia de Bases , Estudios de Casos y Controles , ADN/genética , Femenino , Genotipo , Humanos , Embarazo , Factores de Riesgo
12.
J Neural Transm (Vienna) ; 113(11): 1821-6, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16715208

RESUMEN

Staurosporin, a specific inhibitor of PKC, is widely used in studies of signal transduction pathways. Previous studies have shown that staurosporin induces neurite outgrowth, but the underlying mechanisms remain unclear. Here we report that staurosporin induces neurite outgrowth in HN33 hippocampal cells. Two other PKC inhibitors, Go 6976 (specific for alpha- and beta-isoforms) and rotterlin (a selective inhibitor of PKC delta), have no neuritogenic effect. In addition, staurosporin specifically increases ROS generation. NAC, which inhibits the generation of ROS, suppresses the staurosporin-induced neurite outgrowth in HN33 cells. Further, H(2)O(2) causes neurite outgrowth. Taken together, these results confirm a neuritogenic effect of staurosporin and point to ROS as the signal mediator of staurosporin-induced neurite outgrowth in HN33 hippocampal cells. Theme: Development and regeneration Topic: Neurotrophic factors: receptors and cellular mechanisms.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Hipocampo/metabolismo , Neuritas/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Estaurosporina/farmacología , Animales , Western Blotting , Línea Celular , Hipocampo/efectos de los fármacos , Ratones , Neuritas/metabolismo , Proteína Quinasa C/antagonistas & inhibidores , Proteína Quinasa C/efectos de los fármacos
13.
Arch Pathol Lab Med ; 125(11): 1453-7, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11698001

RESUMEN

OBJECTIVE: To determine whether human papillomavirus (HPV) testing is useful in the evaluation of patients diagnosed with atypical squamous cells of undetermined significance (ASCUS)/low-grade squamous intraepithelial lesion (LSIL) and whether the HPV test is appropriate as an alternative screening method. DESIGN: The results of Papanicolaou (Pap) tests and subsequent hybrid capture tube (HCT) II tests for high-risk-type HPV were analyzed for 457 patients. Among these tests, 208 histologic diagnoses were made and correlated with the results of Pap and HPV tests. The sensitivity and specificity of the Pap test, HPV test, and the combined method of Pap and HPV tests to detect cervical intraepithelial neoplasia (CIN) 2/3 and all CIN were also measured. RESULTS: Sixty (63.8%) of 94 women with LSIL and 31 (26.3%) of 118 women with ASCUS tested positive for high-risk HPV. The sensitivity values for Pap tests in detecting all cases of CIN and CIN 2/3 were 91.4% and 92.9%, respectively. The sensitivity values of HCT II tests using the high-risk probe for detecting all cases of CIN and CIN 2/3 were 62.6% and 88.1%, respectively. Biopsies confirmed that 10 (22.7%) of 44 LSIL patients with high-risk HPV had CIN 2/3, but only 1 (4.5%) of 22 LSIL patients without high-risk HPV had CIN 2/3. CONCLUSION: Testing for high-risk HPV with the HCT II test is useful in the detection of CIN 2/3 in LSIL groups and in the selection of patients for colposcopy in ASCUS groups, but it is not suitable for cervical cancer screening tests.


Asunto(s)
Cuello del Útero/patología , Cuello del Útero/virología , Prueba de Papanicolaou , Papillomaviridae/aislamiento & purificación , Displasia del Cuello del Útero/patología , Displasia del Cuello del Útero/virología , Frotis Vaginal , Biopsia , Carcinoma de Células Escamosas/diagnóstico , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Sensibilidad y Especificidad , Neoplasias del Cuello Uterino/diagnóstico , Neoplasias del Cuello Uterino/patología
15.
Am J Med ; 79(2C): 24-31, 1985 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-3898832

RESUMEN

A 12-week study with two weekly endoscopic assessments was performed in 138 patients to compare the efficacy of sucralfate fine granules (900 mg one-half hour before breakfast, lunch, and dinner, and at bedtime) versus placebo in the healing of gastric ulcers prestratified into corpus, prepyloric, and duodenal ulcer-associated. For corpus and prepyloric ulcers, the respective healing rates achieved by sucralfate at six weeks (69 and 80 percent) and at eight weeks (80 and 93 percent) were significantly (p less than 0.005) better than those obtained with placebo (33 and 25 percent at six weeks, and 41 and 33 percent at eight weeks). The design of the study permitted life-table analysis that further demonstrated the efficacy of sucralfate in these two ulcer types (p less than 0.0001). Symptomatic response was likewise significantly better with sucralfate than with placebo. Similar healing rates and symptomatic responses were observed for patients with duodenal ulcer-associated gastric ulcer but were not significantly better with sucralfate than with placebo. From 38 prospectively obtained clinical, personal, physiologic, and endoscopic characteristics, it was found that ulcer size and a history of pain had significant influence on healing with sucralfate. It is concluded that sucralfate is safe and effective for the treatment of corpus and prepyloric ulcers.


Asunto(s)
Aluminio/uso terapéutico , Antiulcerosos/uso terapéutico , Úlcera Gástrica/tratamiento farmacológico , Análisis Actuarial , Ensayos Clínicos como Asunto , Método Doble Ciego , Úlcera Duodenal/complicaciones , Femenino , Gastroscopía , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Placebos , Distribución Aleatoria , Úlcera Gástrica/complicaciones , Úlcera Gástrica/patología , Sucralfato
16.
Gut ; 25(7): 703-6, 1984 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6376292

RESUMEN

Of 212 patients with duodenal ulcer treated with four weeks of one gram daily cimetidine, 25 had ulcers which underwent no reduction in size despite treatment. The effects of tripotassium dicitrato bismuthate (TDB) tablet four times a day or cimetidine 1.6 g daily on the healing of these cimetidine resistant ulcers were compared in a randomised crossover trial. Ten of 12 patients on tripotassium dicitrato bismuthate and five of 13 patients on high dose cimetidine had complete healing (p less than 0.02). On crossing over, seven of the eight ulcers not healed by high dose cimetidine completely healed with TDB in another four weeks, and one of the two ulcers not healed by TDB healed with high dose cimetidine. Overall, TDB healed 85% of cimetidine resistant ulcers, whereas high dose cimetidine healed 40% (p less than 0.006). Tripotassium dicitrato bismuthate is recommended for cimetidine resistant duodenal ulcers.


Asunto(s)
Antiulcerosos/uso terapéutico , Bismuto/uso terapéutico , Cimetidina/administración & dosificación , Úlcera Duodenal/tratamiento farmacológico , Compuestos Organometálicos , Adolescente , Adulto , Anciano , Cimetidina/uso terapéutico , Ensayos Clínicos como Asunto , Resistencia a Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Distribución Aleatoria , Comprimidos
17.
Clin Radiol ; 35(2): 119-23, 1984 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-6321083

RESUMEN

Endoscopic retrograde cholangiography or percutaneous transhepatic cholangiography was performed in 22 patients suffering from hepatocellular carcinoma who presented with obstructive jaundice. Cholangiographic features included intraluminal filling defects within the major ducts causing complete or partial obstruction, involvement of the ductal system by tumour encasement resulting in a localised stricture or diffuse irregular strictures and dilatations, and displacement and stretching of the extrahepatic or intrahepatic ducts by tumour mass. Eight patients presented with more than one of these cholangiographic features. The observed cholangiographic features, though not specific for hepatocellular carcinoma, have provided an additional differential diagnosis in interpreting cholangiograms. The information obtained from cholangiography has also enabled selection of patients for surgery and allowed more accurate operative planning.


Asunto(s)
Carcinoma Hepatocelular/diagnóstico por imagen , Colangiografía/métodos , Colestasis/diagnóstico por imagen , Neoplasias Hepáticas/diagnóstico por imagen , Adulto , Anciano , Carcinoma Hepatocelular/complicaciones , Carcinoma Hepatocelular/cirugía , Colangiopancreatografia Retrógrada Endoscópica/métodos , Colestasis/etiología , Colestasis/cirugía , Femenino , Humanos , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/cirugía , Masculino , Persona de Mediana Edad
18.
Cancer ; 53(3): 401-5, 1984 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-6198058

RESUMEN

In a prospective clinical trial, 39 patients with advanced hepatocellular carcinoma were randomized to receive either Adriamycin (20 patients) or a combination of 5-fluorouracil, methotrexate, cyclophosphamide, and vincristine (19 patients). Five patients receiving Adriamycin and none receiving quadruple chemotherapy responded (P less than 0.05 in favor of Adriamycin). A further 25 patients were treated with Adriamycin, making a total of 45. The overall objective response rate was 24% (11 patients), with 3 complete remissions and 8 partial remissions. The median survival for Adriamycin-treated patients (13.0 weeks for the first 20 patients and 14.4 weeks for all patients) was longer than those treated by quadruple chemotherapy (6.5 weeks). The difference, however, was not significant by the Wilcoxan test as modified by Gehan. Patients with positive HbsAg had a significantly higher chance of having a response, while serum alpha-fetoprotein levels did not correlate with response.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma Hepatocelular/tratamiento farmacológico , Doxorrubicina/uso terapéutico , Neoplasias Hepáticas/tratamiento farmacológico , Adulto , Ensayos Clínicos como Asunto , Ciclofosfamida/administración & dosificación , Femenino , Fluorouracilo/administración & dosificación , Antígenos de Superficie de la Hepatitis B/análisis , Humanos , Masculino , Metotrexato/administración & dosificación , Persona de Mediana Edad , Estudios Prospectivos , Distribución Aleatoria , Vincristina/administración & dosificación , alfa-Fetoproteínas/análisis
19.
Endoscopy ; 16(1): 24-5, 1984 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-6697979

RESUMEN

We report here a simple method of fixing a nasogastric tube to an upper GI endoscope which allows the tube to be inserted under vision when the normal upper gastrointestinal passage have been distorted by previous surgery or disease.


Asunto(s)
Endoscopía/métodos , Intubación Gastrointestinal/métodos , Neoplasias Esofágicas/cirugía , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias
20.
Cancer ; 52(10): 1952-6, 1983 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-6313178

RESUMEN

Tumor cells were recovered from the right atrium in three of five patients during hepatic resection for hepatocellular carcinoma. Mechanical factors during blunt mobilization and rotation of the hepatic tumor appeared to be responsible for tumor dislodgement into the venous circulation. Tumor embolization to the lungs may be one of the important reasons for the poor results of surgery in this disease. Two possible technical and therapeutic modifications are suggested to prevent or neutralize this phenomenon.


Asunto(s)
Carcinoma Hepatocelular/cirugía , Atrios Cardíacos , Neoplasias Hepáticas/cirugía , Células Neoplásicas Circulantes , Sangre , Carcinoma Hepatocelular/patología , Femenino , Humanos , Neoplasias Hepáticas/patología , Neoplasias Pulmonares/etiología , Neoplasias Pulmonares/secundario , Masculino , Métodos , Persona de Mediana Edad , Proyectos Piloto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA